Sime Dx

London, United Kingdom Founded: 2010 • Age: 16 yrs
Point-of-care digital diagnostics are developed and provided by Sime Dx.
Request Access

About Sime Dx

Sime Dx is a company based in London (United Kingdom) founded in 2010.. Sime Dx has raised $970.9 thousand across 5 funding rounds from investors including Oxford Technology and European Union. The company has 8 employees as of March 31, 2022. Sime Dx offers products and services including Point-of-care Device and AI Diagnostic Platform. Sime Dx operates in a competitive market with competitors including Viz.ai, PathAI, Deepcell, Aignostics and Deciphex, among others.

  • Headquarter London, United Kingdom
  • Employees 8 as on 31 Mar, 2022
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Sime Diagnostics Limited
  • Date of Incorporation 07 Feb, 2014
  • Jurisdiction LONDON, ENGLAND
Operational Areas
Healthcare → Health Technology & Digital Health
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Health Technology & Digital Health
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $970.9 K (USD)

    in 5 rounds

  • Latest Funding Round
    $626 K (USD), Seed

    May 12, 2020

  • Investors
  • Employee Count
    8

    as on Mar 31, 2022

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Sime Dx

Sime Dx offers a comprehensive portfolio of products and services, including Point-of-care Device and AI Diagnostic Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Rapidly predicts lung diseases in ICU using AI technology.

Offers algorithms for early respiratory disease prediction in neonates.

People of Sime Dx
Headcount 10-50
Employee Profiles 5
Employee Profiles
People
Peter Schousboe
Head of R&D
People
Mark Edwards
Chief Financial Officer
People
Kadia Barry ( ACCA, MBA, FMVA®)
Financial Controller
People
Hugh Reid
Chief Technology Officer

Unlock access to complete

Funding Insights of Sime Dx

Sime Dx has successfully raised a total of $970.9K across 5 strategic funding rounds. The most recent funding activity was a Seed round of $626 thousand completed in May 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 5
  • Last Round Seed — $625,996
  • First Round

    (09 Apr 2014)

  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
May, 2020 Amount Seed - Sime Dx Valuation

investors

Feb, 2019 Amount Seed - Sime Dx Valuation

investors

Apr, 2016 Amount Seed - Sime Dx Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Sime Dx

Sime Dx has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Oxford Technology and European Union. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Early-stage micro-VC investments are focused on UK companies.
Founded Year Domain Location
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Sime Dx

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Sime Dx

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Sime Dx Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Sime Dx

Sime Dx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Viz.ai, PathAI, Deepcell, Aignostics and Deciphex, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
AI and cloud-powered software for stroke care coordination is developed.
domain founded_year HQ Location
Provider of AI-based solutions for clinical diagnosis of cancer and other diseases
domain founded_year HQ Location
AI-powered single cell classification and isolation technology for clinical research
domain founded_year HQ Location
AI-based pathology diagnostic software is provided for medical analysis.
domain founded_year HQ Location
Digital pathology software is developed for clinical and veterinary productivity.
domain founded_year HQ Location
Provides image analysis and data mining solutions for quantitative digital pathology in the healthcare industry
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Frequently Asked Questions about Sime Dx

When was Sime Dx founded?

Sime Dx was founded in 2010 and raised its 1st funding round 4 years after it was founded.

Where is Sime Dx located?

Sime Dx is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.

Is Sime Dx a funded company?

Sime Dx is a funded company, having raised a total of $970.9K across 5 funding rounds to date. The company's 1st funding round was a Seed of $141.24K, raised on Apr 09, 2014.

How many employees does Sime Dx have?

As of Mar 31, 2022, the latest employee count at Sime Dx is 8.

What does Sime Dx do?

Founded in 2010, Sime Dx is headquartered in London, United Kingdom. Digital diagnostics for point-of-care applications are created and distributed by the company within the healthcare sector. Services focus on enabling rapid testing and analysis directly at patient sites, supporting clinical decision-making. Operations emphasize technology integration for diagnostics, with the domain simedx.com serving as the primary online presence.

Who are the top competitors of Sime Dx?

Sime Dx's top competitors include Aignostics, Deciphex and Pictor Labs.

What products or services does Sime Dx offer?

Sime Dx offers Point-of-care Device and AI Diagnostic Platform.

Who are Sime Dx's investors?

Sime Dx has 2 investors. Key investors include Oxford Technology, and European Union.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available